Search
for
Sort by
Research 511–540 of 775
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- The JAK/STAT signaling pathway: from bench to clinic
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Skin Pigmentation Types, Causes and Treatment—A Review
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Hair follicle immune privilege and its collapse in alopecia areata
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Alopecia Areata: An Updated Review for 2023
- Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment
- Understanding autoimmunity of vitiligo and alopecia areata
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- A Review of Edible Jujube, the Ziziphus jujuba Fruit: A Heath Food Supplement for Anemia Prevalence
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Alopecia Areata: Current Treatments and New Directions
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Frontiers in alopecia areata pathobiology research
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion